These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8842621)

  • 41. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
    Lin R; Brown F; James S; Jones J; Ekinci E
    Diabet Med; 2021 May; 38(5):e14528. PubMed ID: 33496979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring glycaemic control in patients with diabetes mellitus.
    Sodi R; McKay K; Dampetla S; Pappachan JM
    BMJ; 2018 Nov; 363():k4723. PubMed ID: 30459149
    [No Abstract]   [Full Text] [Related]  

  • 43. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing Insulin Therapy: Basal Insulin and Beyond.
    Aroda V; Johnson EL; Novak L; Skolnik N
    J Fam Pract; 2018 Oct; 67(10 Suppl):. PubMed ID: 30423012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Self Monitoring of Blood Glucose Among Patients with Type 2 Diabetes Mellitus in Eastern Nigeria: Need for Multi-strategic Interventions.
    Ugwu ET; Orjioke CJG; Young EE
    Curr Diabetes Rev; 2018; 14(2):175-181. PubMed ID: 27758706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucose monitoring in women with insulin-requiring gestational diabetes mellitus.
    de Veciana M
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S25-30. PubMed ID: 9816484
    [No Abstract]   [Full Text] [Related]  

  • 47. Changes in depressive symptoms and glycemic control in diabetes mellitus.
    Georgiades A; Zucker N; Friedman KE; Mosunic CJ; Applegate K; Lane JD; Feinglos MN; Surwit RS
    Psychosom Med; 2007 Apr; 69(3):235-41. PubMed ID: 17420441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of self-monitoring of glucose on distress and self-efficacy in people with non-insulin-treated Type 2 diabetes: a randomized controlled trial.
    Malanda UL; Bot SD; Kostense PJ; Snoek FJ; Dekker JM; Nijpels G
    Diabet Med; 2016 Apr; 33(4):537-46. PubMed ID: 26171942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood glucose monitoring.
    Goldstein AO
    J Fam Pract; 1994 Aug; 39(2):187-8. PubMed ID: 8057072
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolic control matters: Why is the message lost in the translation? The need for realistic goal-setting in diabetes care.
    Wolpert HA; Anderson BJ
    Diabetes Care; 2001 Jul; 24(7):1301-3. PubMed ID: 11423522
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of data management on a central server on HbA1c levels in insulin-requiring patients.
    Davidson MB; Lewis G
    Diabetes Care; 2000 May; 23(5):706-7. PubMed ID: 10834438
    [No Abstract]   [Full Text] [Related]  

  • 52. Medical Treatment of Diabetes Mellitus.
    Skugor M
    Cleve Clin J Med; 2017 Jul; 84(7 Suppl 1):S57-S61. PubMed ID: 28708483
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationship between home glucose testing and hemoglobin Alc in type II diabetes patients.
    Wieland LD; Vigil JM; Hoffman RM; Janis LW
    Am J Health Syst Pharm; 1997 May; 54(9):1062-5. PubMed ID: 9143655
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
    Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [What do the new guidelines on the treatment of diabetes?].
    Bringer J
    Rev Prat; 2013 Jun; 63(6):748-50. PubMed ID: 23923744
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
    Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
    Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of blood glucose monitoring in relation to glycemic control among patients with type 2 diabetes in the UK.
    Secnik K; Yurgin N; Lage MJ; McDonald-Everett C
    J Diabetes Complications; 2007; 21(3):181-6. PubMed ID: 17493552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.